Beneficial Actions of Essential Fatty Acids in Streptozotocin-Induced Type 1 Diabetes Mellitus

Junhui Shen; Li Zhang; Yuanqi Wang; Zhiqing Chen; Jian Ma; Xiaoyun Fang; Undurti N Das; Ke Yao

doi:10.3389/fnut.2022.890277

Beneficial Actions of Essential Fatty Acids in Streptozotocin-Induced Type 1 Diabetes Mellitus

Front Nutr. 2022 May 19:9:890277. doi: 10.3389/fnut.2022.890277. eCollection 2022.

Authors

Junhui Shen^{1

2}, Li Zhang^{1

2}, Yuanqi Wang^{1

2}, Zhiqing Chen^{1

2}, Jian Ma^{1

2}, Xiaoyun Fang^{1

2}, Undurti N Das^{3

4}, Ke Yao^{1

2}

Affiliations

¹ Eye Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
² Key Laboratory of Ophthalmology of Zhejiang Province, Hangzhou, China.
³ UND Life Sciences, Battle Ground, WA, United States.
⁴ Department of Biotechnology, Indian Institute of Technology, Kandi, India.

Abstract

The essential fatty acids (EFA), n3 alpha-linolenic acid (ALA), and n6 linoleic acid (LA) are of benefit in diabetes mellitus, but their mechanisms of action are unknown. We, therefore, examined the effects of EFAs on the metabolism, gut microbiota, and inflammatory and retinal histopathology indices in streptozotocin (STZ)-induced type 1 diabetes mellitus (T1DM) animals, and we assessed the levels of vitreal lipoxin A4 (LXA4)-derived from LA-in subjects with diabetic retinopathy (DR). STZ-induced T1DM rats received LA or ALA 100 μg/day intraperitoneally on alternate days for 21 days, and their blood glucose; lipid profile; plasma, hepatic, and retinal fatty acid profiles (by gas chromatography); retinal histology; activities of hepatic and retinal desaturases; and inflammatory markers (by qRT-PCR) were evaluated. Gut microbiota composition was assayed by 16S rDNA sequencing technology of the fecal samples, and their short-chain fatty acids and bile acids were assayed by gas chromatography, liquid chromatography coupled with tandem mass spectrometry, respectively. The human vitreal fatty acid profiles of subjects with proliferative DR and LXA4 levels were measured. LA and ALA significantly improved the plasma glucose and lipid levels; increased the abundance of Ruminococcaceae (the ALA-treated group), Alloprevotella, Prevotellaceae_Ga6A1_group, Ruminococcaceae_UCG_010, and Ruminococcus_1 (the LA-treated group) bacteria; enhanced acetate and butyrate levels; and augmented fecal and hepatic concentrations of cholic acid, chenodeoxycholic acid, and tauro ursodeoxycholic acid in ALA- and LA-treated animals. Significant STZ-induced decreases in plasma LA, gamma-linolenic acid, arachidonic acid, and ALA levels reverted to near normal, following LA and ALA treatments. Significant changes in the expression of desaturases; COX-2, 5-LOX, and 12-LOX enzymes; and cytokines in T1DM were reverted to near normal by EFAs. DR subjects also had low retinal LXA4 levels. The results of the present study show that ALA and LA are of significant benefit in reversing metabolism, gut microbiota, and inflammatory and retinal index changes seen in T1DM, suggesting that EFAs are of benefit in diabetes mellitus.

Keywords: bile acids; diabetes; fatty acids; gut microbiome; inflammation; short-chain fatty acids.